These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
779 related items for PubMed ID: 19689975
1. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Gimeno JR, Tomé-Esteban M, Lofiego C, Hurtado J, Pantazis A, Mist B, Lambiase P, McKenna WJ, Elliott PM. Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975 [Abstract] [Full Text] [Related]
3. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A. G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218 [Abstract] [Full Text] [Related]
5. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613 [Abstract] [Full Text] [Related]
6. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico]. Giani P, Avanzini F, Bagliani G, Galati A, Pucci P, Santoro E. G Ital Cardiol; 1995 Jan 01; 25(1):77-87. PubMed ID: 7642014 [Abstract] [Full Text] [Related]
14. Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Grimm W, Christ M, Maisch B. Pacing Clin Electrophysiol; 2005 Jan 14; 28 Suppl 1():S207-10. PubMed ID: 15683498 [Abstract] [Full Text] [Related]
15. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior]. Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE. Z Kardiol; 2000 Jan 14; 89 Suppl 3():194-205. PubMed ID: 10810803 [Abstract] [Full Text] [Related]
16. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy]. Sadoul N, de Chillou C, Aliot E, McKenna WJ. Arch Mal Coeur Vaiss; 1999 Apr 14; 92 Spec No 1():65-73. PubMed ID: 10326160 [Abstract] [Full Text] [Related]
20. Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. Dimitrow PP, Chojnowska L, Rudzinski T, Piotrowski W, Ziólkowska L, Wojtarowicz A, Wycisk A, Dabrowska-Kugacka A, Nowalany-Kozielska E, Sobkowicz B, Wróbel W, Aleszewicz-Baranowska J, Rynkiewicz A, Loboz-Grudzien K, Marchel M, Wysokinski A. Eur Heart J; 2010 Dec 14; 31(24):3084-93. PubMed ID: 20843960 [Abstract] [Full Text] [Related] Page: [Next] [New Search]